Racial and Geographic Differences in Endometrial Cancer Death
Oncology · 2024
DOI: 10.1159/000541683 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology, 2024. Verfasst von Jia Yi Tan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, New York Medical College at Saint Michael's Medical Center, Newark, New Jersey, USA. Hauptthemen laut MEDLINE: Endometrial Neoplasms. Die Arbeit nennt 20 Literaturangaben.
Abstract (Originalsprache)
Introduction
In the USA, endometrial cancer incidence rose by 4.5% annually from 1999 to 2015, reaching 18 per 100,000 women, with a disproportionate impact on African American women. Despite advancements in endometrial cancer research, racial disparities in mortality rates persist. Our retrospective cohort study aimed to investigate the mortality trends and disparities among patients with endometrial cancer in the USA.
Methods
Patients with endometrial cancer mortality from 1999 to 2020 were analyzed from the Centers for Disease Control and Prevention’s Wide-Ranging Online Data for Epidemiologic Research (CDC WONDER). Age-adjusted mortality rates (AAMRs) per 100,000 individuals were compared across different races and geographical regions.
Results
From 1999 to 2020, endometrial cancer accounted for 90,145 deaths in the USA. Overall, the AAMRs of endometrial cancer increased significantly from 2.50 (95% CI, 2.41–2.58) in 1999 to 3.94 (95% CI, 3.85–4.04) per 100,000 individuals in 2020, with an AAPC of +2.23 (95% CI, 1.39–3.07). The highest AAMR was observed among African Americans (2.69 [95% CI, 2.65–2.74]), followed by whites (1.44 [95% CI, 1.43–1.45]), Hispanics (1.16 [95% CI, 1.13–1.20]), Asians (1.00 [95% CI, 0.96–1.04]), and American Indians (0.99 [95% CI, 0.88–1.10]). The highest AAMR from endometrial cancer was recorded in the Northeast region (1.73 [95% CI, 1.71–1.76]).
Conclusion
There was an increasing trend of mortality rates from endometrial cancer in the last 2 decades, which disproportionately affected African Americans. Targeted interventions are warranted to address the mortality disparities among patients with endometrial cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, New York Medical College at Saint Michael's Medical Center, Newark, New Jersey, USA.
- Department of Internal Medicine/Pediatrics, Corewell Health, Royal Oak, Michigan, USA.
- Department of Internal Medicine, Saint Vincent's Medical Center, Bridgeport, Connecticut, USA.
- Medical Student, St. George's University, Saint George's, Grenada.
- Division of Hematology/Oncology, Department of Internal Medicine, New York Medical College at Saint Michael's Medical Center, Newark, New Jersey, USA.
Zitieren
APA
Tan, J. Y., Yeo, Y. H., Thong, J. Y., Saleh, S., Mbenga, K., Guron, G., & Shaaban, H. S. (2024). Racial and Geographic Differences in Endometrial Cancer Death. Oncology. https://doi.org/10.1159/000541683
Vancouver
Tan JY, Yeo YH, Thong JY, Saleh S, Mbenga K, Guron G, et al. Racial and Geographic Differences in Endometrial Cancer Death. Oncology. 2024. doi:10.1159/000541683
BibTeX
@article{Tan2024,
author = {Tan, Jia Yi and Yeo, Yong Hao and Thong, Jia Yean and Saleh, Sabera and Mbenga, Kelly and Guron, Gunwant and Shaaban, Hamid S},
title = {Racial and Geographic Differences in Endometrial Cancer Death},
journal = {Oncology},
year = {2024},
doi = {10.1159/000541683}
}
EUVIMED